MSD Pharmaceuticals (India), the local affiliate of Merck & Co, has launched Gardasil (quadrivalent human papillomavirus recombinant vaccine), as India's first vaccine to help prevent cervical cancer.The vaccine, first launched globally in 2006 and approved in more than 100 countries worldwide, is touted to be the only vaccine that helps protect against 4 types (type 6,11,16,18) of HPV.
The details can be read here.
No comments:
Post a Comment